PD

Prova Dhara

Active Director Director DIN 10242852
DIN 10242852 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Prova Dhara

Data last updated:

Prova Dhara is a Director at Octaus Medical Private Limited (since 2023). The company operates in Paper. Octaus Medical Private Limited reported revenue of ₹1.1 Lakh (FY 2025).

DIN 10242852
Primary Designation Director
Industry Paper
First Appointment 18 Jul 2023
Oldest Company Age 3 yrs
Largest company Octaus Medical Private Limited · ₹1.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Octaus Medical Private Limited U21001WB2023PTC263586
Director18 Jul 20232023₹1.1 Lakh (FY 2025)Active

Board colleagues of Prova Dhara

NameDINCompanyDesignation
Baishakhi Karmakar10242851Octaus Medical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Octaus Medical Private Limited
Premium access

Shareholding and investment profile for Prova Dhara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prova Dhara

Prova Dhara currently holds 1 directorship: Octaus Medical Private Limited (Director, since 18 Jul 2023, revenue ₹1.1 Lakh (FY 2025)).

Prova Dhara was first appointed on 18 Jul 2023 as Director at Octaus Medical Private Limited.

The current boards of Prova Dhara's companies include Baishakhi Karmakar (Octaus Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available